April 22, 2015

Kinney Drugs, the New York and Vermont drug store division of KPH Healthcare Services Inc., continues to roll out innovative health programs.

April 21, 2015

Efficient Collaborative Retail Marketing just did an unconventional acquisition to provide the company with a new source of growth by applying its successful model of connecting buyers and sellers to the media world.

April 21, 2015

The personal care products industry supports legislation introduced Monday that would bring greater FDA oversight. 

April 14, 2015

Diplomat Pharmacy announced it will distribute Novartis' new medicine Jadenu, which is indicated to treat patients with chronic iron overload. 

April 7, 2015

A new indication for Boehringer Ingelheim Pharmaceuticals's Pradaxa may be on the horizon. 

March 11, 2015

A coalition of state attorneys general is organized by New York Attorney General Eric Schneiderman to investigate herbal supplements. 

 

March 4, 2015

Tooth decay is one of the most common chronic conditions among children in the United States, according to the Centers for Disease Control and Prevention, with about 20% of children ages 5 years to 11 years old having at least one untreated decayed tooth. The good news is that tooth decay is preventable.

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

February 26, 2015

The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.

February 24, 2015

Mylan has been appointed as the exclusive India distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, by Gilead Sciences. 

February 20, 2015

2015 Dietary Guidelines Advisory Committee identifies 10 "shortfall" nutrients in its dietary guideline recommendations submitted Thursday. 

February 17, 2015

The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.

February 10, 2015

As part of its ongoing exploration of how pharmacists can engage in interdisciplinary efforts to promote oral health, the American Pharmacists Association Foundation has teamed up with America’s ToothFairy: National Children’s Oral Health Foundation.

February 10, 2015

GNC on Monday announced that it refuted the claims made by the New York State Attorney General in his Feb. 2 letter.

February 9, 2015

Bayer HealthCare on Monday announced the launch of the ProHeart Path Tool. 

February 5, 2015

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

January 26, 2015

The Food and Drug Administration last week announced approval for Bexsero, a vaccine intended to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 years through 25 years of age.

 

January 7, 2015

CVS/pharmacy has revealed the spring 2015 collection of its exclusive Nuance Salma Hayek line, featuring new products for hair and skin.

January 7, 2015

We didn’t go crazy making a lot of predictions for 2015. That’s because 2015 is the year so many of our past predictions will come true, as the forces of healthcare consumerism and mobile technology collide to forever change the way health care is purchased, consumed and delivered. Call it the Big Bang of retail health.

December 22, 2014

The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.

December 22, 2014

The Food and Drug Administration has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs.

December 22, 2014

The Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.

December 22, 2014

The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.